Authors: Ferry, DR Deakin, M Baddeley, J Daryanani, S Bramhall, S Anderson, DA Wakelam, MJO Doran, J Pemberton, G Young, AM Buckels, J Kerr, DJ

Citation: Dr. Ferry et al., A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: Correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints, ANN ONCOL, 11(9), 2000, pp. 1165-1170

Authors: Young, AN Daryanani, S Kerr, DJ

Citation: An. Young et al., Can pharmacokinetic monitoring improve clinical use of fluorouracil?, CLIN PHARMA, 36(6), 1999, pp. 391-398

Authors: Daryanani, S Wilde, JT

Citation: S. Daryanani et Jt. Wilde, Relapsing thrombotic thrombocytopenic purpura in association with recurrent pancreatitis, CLIN LAB H, 20(5), 1998, pp. 317-318